Posted Oct. 30, 2013 at 5:34 p.m.

Premium Lock Aerie Pharma closes IPO, raising $68.4M

Published: 2013-10-30 17:34:02
Updated: 2013-10-30 17:34:02

Aerie Pharmaceuticals Aerie Pharmaceuticals

Glaucoma drug developer Aerie Pharmaceuticals (NASDAQ:AERI) closed its initial public offering of stock Wednesday raising a total of $68.4 million that the company plans to use for clinical trials....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll